BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...

If this stock market is shaping up like 2008, here’s where we could be headed next, says strategist

Those looking for a bit of good news to start the week may have to cast the net further out. Stocks are tilting lower as COVID-19 cases flare up in China, threatening more lockdowns. And the plate was...

‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy

If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...

As stock-market turbulence revs up, this ETF theme has drawn 32% of flows in 2022 so far: ‘This isn’t a flash in the pan’

Thank god its Thursday! The Nasdaq Composite posted its first correction since March and equity benchmarks were trying to stage a mini rally, at last check on Thursday. Is this the beginning of the en...